fludarabine has been researched along with tn14003 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burger, JA; Burger, M; Fujii, N; Hartmann, T; Kipps, TJ; Krome, M; Rawluk, J; Tamamura, H | 1 |
1 other study(ies) available for fludarabine and tn14003
Article | Year |
---|---|
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Topics: Actins; Apoptosis; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mitogen-Activated Protein Kinases; Molecular Weight; Oligopeptides; Peptides; Receptors, CXCR4; Stromal Cells; Structure-Activity Relationship; Time Factors; Vidarabine | 2005 |